Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol

Abstract

This study aims to evaluate the reliability of repeated graded workload treadmill testing (G-test; 2 mph; 0% grade, increasing 2% every 2 min) and to compare the reliability of a constant workload treadmill protocol (C-test; 2 mph; 12% grade) versus the graded workload treadmill protocol in patients with intermittent claudication, studied longitudinally.

A clinical trial investigating an orally stable prostacycline derivative that included 330 patients with intermittent claudication was performed. The trial employed three active treatment groups and one placebo group. Because there were no significant inter-group differences at baseline or after treatment, data from all groups were pooled for the evaluation of treadmill test reliability. Treadmill data were obtained from a 2-week run-in phase where three G-tests were performed, as well as from the beginning and the end of a 3-month double-blind phase where a G-test and a C-test were performed in random order. Treadmill test reliability was described through test process-related and between-subject variances and also using variance-derived parameters such as the reliability coefficient (RC) and the relative precision (RP). A higher value for the RC and a lower value for the RP indicate that the test variability is predominantly due to between-subject variance and not to test process-related variance. Estimates of variance were described for both the maximal or absolute claudication distance (ACD) and the initial claudication distance (ICD) with each treadmill test. Reliability estimates are reported for the total study sample and for patients with baseline claudication distances <300 feet and .300 feet (approximately <100 m; .100 m), as measured with the C-test. The cut-off value was empirically chosen to separate severely diseased from mild to moderately diseased claudicants. Theoretical considerations suggest that reliability measures may differ in these subgroups. With repeated testing during the run-in phase for the measure of ACD, the G-test had an RC of 0.952 and an RP of 21.9%. With the comparison of both test protocols in the entire study population for the measurement of ACD, the G-test had an RC of 0.902 and an RP of 31.3%, while the C-test had an RC of 0.876 and an RP of 35.2%. The results for ICD on the G-test were an RC of 0.809 and an RP of 43.7%, while the C-test had an RC of 0.737 and an RP of 51.3%. The reliability of the ACD measurement for RC and RP was numerically superior to those for the ICD for both protocols. In patients with a baseline ACD <300 feet, the RC for ACD on the G-test was 0.827 and the RP was 41.4%. In contrast, on the C-test the RC decreased to 0.250 and the RP increased to 86.6%. These changes in RC and RP were due to a marked decrease in the between-subject variance, demonstrating the inability of the C-test to separate appropriately the different claudication distances in populations with highly limited baseline claudication distances.

During a run-in phase, the G-test has excellent test characteristics. During the longitudinal phase of a trial, the reliability of G-tests and C-tests are comparable in the entire study population. However, in patients with low claudication distances, the G-test should be given preference over the C-test.

Keywords

exercise testing intermittent claudication intra-class correlation coefficient peripheral arterial disease relative precision reliability coefficient

References

Criqui MH , Fronek A , Klauber MR , Barret-Conner E , Gabriel S. The sensitivity, specificity and predictive value of traditional clinical evaluation of peripheral arterial disease: results from a non-invasive testing in a defined population. Circulation 1985; 71: 516-521.

Ruckley CV. Symptomatic and asymptomatic disease. In: Fowkes FGR (ed). Epidemiology of peripheral vascular disease. Heidelberg: Springer Verlag, 1991: 97-108.

De Baker G , Kornitzer M , Sobolski J , Denolin H. Intermittent claudication epidemiology and natural history. Acta Cardiologica 1979; XXXIV: 115-124.

Criqui MH , Langer RD , Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-386.

Jaeger KA , Labs KH , FitzGerald DE , Labs R. Epidemiology, risk and hemodynamics. In: Labs KH , Schmid-Schoenbein GW , Schoenharting MM (eds). Leukocytes and endothelial interactions. Barcelona: Prous Science Publishers, 1995: 103-121.

Labs KH , Roessner M , Aschwanden M , Jeanneret Ch , Gehrig A , Jaeger KA. Reproducibility of fixed load treadmill testing. J Vasc Invest 1998; 4: 55-60.

Gardner AW , Skinner JS , Vaughan NR , Bryant CX , Smith LK. Comparison of three progressive exercise protocols in peripheral vascular occlusive disease. Angiology 1992; 43: 661-671.

Gardner AW , Skinner JS , Cantwell BW , Smith LK. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 1991; 23: 402-408.

Gardner AW , Skinner JS , Smith LK. Effects of handrail support on claudication and hemodynamic responses to single-stage and progressive treadmill protocols in peripheral arterial occlusive disease. Am J Cardiol 1991; 68: 99-105.

10.

Hiatt WR , Hirsch AT , Regensteiner JG , Brass EP. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Circulation 1995; 91: 1-8.

11.

Lièvre M , Azoulay S , Lion L , Morand S , Girre JP , Boissel JP. A dose-effect study of beraprost sodium in intermittent claudication. J Cardiovasc Pharmacol 1996; 27: 788-793.

12.

Cachovan M , Rogatti W , Creutzig A et al. Treadmill testing for evaluation of claudication: comparison of constant-load and graded-exercise tests. Eur J Vasc Endovasc Surg 1997; 14: 238-243.

13.

Lindgarde F , Labs KH , Roessner M. The pentoxifylline experience: exercise testing reconsidered. Vasc Med 1996; 1: 145-154.

14.

Pischel T , Schueler A , Tschoepl M , Holtz DJ , Labs KH. Klinische Wertigkeit und Reproduzierbarkeit von Laufbandmessungen bei konstanten Versuchsbedingungen. Vasa 1995; 45 (suppl): 61-62.

15.

Maass U , Alexander K , Schneider B , Toeroek M. Reproduzierbarkeit laufband-ergometrischer Untersuchungen zur Bestimmung der beschwerdefreien Gehstrecke bei Patienten mit arterieller Verschlusskrankheit. Vasa 1980; 9: 182-185.

16.

Note for guidance on the clinical investigation of medicinal products in the treatment of chronic peripheral arterial occlusive disease. The European Agency for the Evaluation of Medicinal Products. CPMP/EWP/233/95final.